Leflunomide analogs for treating rheumatoid arthritis
AssigneeUnitech Pharmaceuticals, Inc.
InventorsAn-Rong Lee, Wen-Hsin Huang, Jiajiu Shaw
Life of this patent
Estimating the term…
Abstract
Novel leflunomide analogs were synthesized and evaluated in-vivo. Based on the in-vivo studies, these analogs are surprisingly effective for treating rheumatoid arthritis.
Claims28
A compound of the formula (I)
- or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br, 2,4-(Br)2, 3-CF3, 4CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br.
A pharmaceutical composition comprising a compound of the formula (I)
- or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br, 2,4-(Br)2, 3-CF3, 4-CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br.
A method of treating rheumatoid arthritis comprising administering to a patient an effective amount of a pharmaceutical composition comprising a compound of the formula (I)
- or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br, 2,4-(Br)2, 2-CF3, 3-CF3, 4-CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 2-OCH3, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br.
A method of treating rheumatoid arthritis comprising administering to a patient a therapeutically effective amount of a composition comprising a compound of the formula (I)
- or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br,2,4-(Br)2, 2-CF3, 3-CF3, 4-CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 2-OCH3, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br, and a drug selected from the group consisting of dexamethasone, ibuprofen, leflunomide, malononitrilamide, diclofenac sodium, diclofenac potassium, naproxen, naproxen sodium, and combinations thereof.
Dependencies are inferred from the claim text.